TEADS HOLDING CO (TEAD) Fundamental Analysis & Valuation

NASDAQ:TEAD • US69002R1032

Current stock price

0.6301 USD
-0.03 (-5.11%)
At close:
0.657 USD
+0.03 (+4.27%)
After Hours:

This TEAD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. TEAD Profitability Analysis

1.1 Basic Checks

  • In the past year TEAD has reported negative net income.
  • TEAD had a positive operating cash flow in the past year.
  • In multiple years TEAD reported negative net income over the last 5 years.
  • Each year in the past 5 years TEAD had a positive operating cash flow.
TEAD Yearly Net Income VS EBIT VS OCF VS FCFTEAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M -500M

1.2 Ratios

Industry RankSector Rank
ROA -38.94%
ROE -541.79%
ROIC N/A
ROA(3y)-12.51%
ROA(5y)-7.86%
ROE(3y)-179.17%
ROE(5y)-108.9%
ROIC(3y)N/A
ROIC(5y)N/A
TEAD Yearly ROA, ROE, ROICTEAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400 -500

1.3 Margins

  • TEAD's Gross Margin has improved in the last couple of years.
  • TEAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.32%
GM growth 5Y8.92%
TEAD Yearly Profit, Operating, Gross MarginsTEAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20

1

2. TEAD Health Analysis

2.1 Basic Checks

  • TEAD has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TEAD has more shares outstanding
  • Compared to 1 year ago, TEAD has a worse debt to assets ratio.
TEAD Yearly Shares OutstandingTEAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
TEAD Yearly Total Debt VS Total AssetsTEAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 0.29, we must say that TEAD is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 6.52 is on the high side and indicates that TEAD has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 6.52
Debt/FCF N/A
Altman-Z 0.29
ROIC/WACCN/A
WACCN/A
TEAD Yearly LT Debt VS Equity VS FCFTEAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • TEAD has a Current Ratio of 1.10. This is a normal value and indicates that TEAD is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.10 indicates that TEAD should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
TEAD Yearly Current Assets VS Current LiabilitesTEAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. TEAD Growth Analysis

3.1 Past

  • TEAD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1525.00%.
  • Looking at the last year, TEAD shows a very strong growth in Revenue. The Revenue has grown by 46.14%.
  • Measured over the past years, TEAD shows a small growth in Revenue. The Revenue has been growing by 5.30% on average per year.
EPS 1Y (TTM)-1525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)46.14%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%50.15%

3.2 Future

  • TEAD is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -129.40% yearly.
  • Based on estimates for the next years, TEAD will show a quite strong growth in Revenue. The Revenue will grow by 10.36% on average per year.
EPS Next Y-1502.5%
EPS Next 2Y-300.31%
EPS Next 3Y-129.4%
EPS Next 5YN/A
Revenue Next Year44.2%
Revenue Next 2Y19.59%
Revenue Next 3Y13.15%
Revenue Next 5Y10.36%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TEAD Yearly Revenue VS EstimatesTEAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
TEAD Yearly EPS VS EstimatesTEAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4

0

4. TEAD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TEAD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TEAD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TEAD Price Earnings VS Forward Price EarningsTEAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.12
TEAD Per share dataTEAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • TEAD's earnings are expected to decrease with -129.40% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-300.31%
EPS Next 3Y-129.4%

0

5. TEAD Dividend Analysis

5.1 Amount

  • No dividends for TEAD!.
Industry RankSector Rank
Dividend Yield 0%

TEAD Fundamentals: All Metrics, Ratios and Statistics

TEADS HOLDING CO

NASDAQ:TEAD (3/27/2026, 8:00:01 PM)

After market: 0.657 +0.03 (+4.27%)

0.6301

-0.03 (-5.11%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-05
Earnings (Next)05-07
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change70.1%
Market Cap0
Revenue(TTM)1.30B
Net Income(TTM)-517.07M
Analysts76
Price Target2.04 (223.76%)
Short Float %N/A
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.56%
Min EPS beat(2)-107.12%
Max EPS beat(2)100%
EPS beat(4)1
Avg EPS beat(4)-77.53%
Min EPS beat(4)-198.22%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)2.48%
EPS beat(12)7
Avg EPS beat(12)332.52%
EPS beat(16)9
Avg EPS beat(16)225.21%
Revenue beat(2)0
Avg Revenue beat(2)-4.84%
Min Revenue beat(2)-6.82%
Max Revenue beat(2)-2.86%
Revenue beat(4)1
Avg Revenue beat(4)-3.45%
Min Revenue beat(4)-6.82%
Max Revenue beat(4)0.36%
Revenue beat(8)1
Avg Revenue beat(8)-4.64%
Revenue beat(12)2
Avg Revenue beat(12)-4.31%
Revenue beat(16)5
Avg Revenue beat(16)-2.56%
PT rev (1m)0%
PT rev (3m)12.36%
EPS NQ rev (1m)-48.59%
EPS NQ rev (3m)-44.56%
EPS NY rev (1m)12.18%
EPS NY rev (3m)10.48%
Revenue NQ rev (1m)-8.29%
Revenue NQ rev (3m)-4.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF 7.53
P/B 0.6
P/tB N/A
EV/EBITDA 10.12
EPS(TTM)-0.57
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)0.08
OCFY13.29%
SpS14.31
BVpS1.05
TBVpS-6.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.94%
ROE -541.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.99%
FCFM N/A
ROA(3y)-12.51%
ROA(5y)-7.86%
ROE(3y)-179.17%
ROE(5y)-108.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.32%
GM growth 5Y8.92%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 6.52
Debt/FCF N/A
Debt/EBITDA 12.27
Cap/Depr 34.11%
Cap/Sales 1.75%
Interest Coverage N/A
Cash Conversion 14.99%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 0.29
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)73.54%
Cap/Depr(5y)83.99%
Cap/Sales(3y)1.95%
Cap/Sales(5y)2.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-1502.5%
EPS Next 2Y-300.31%
EPS Next 3Y-129.4%
EPS Next 5YN/A
Revenue 1Y (TTM)46.14%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%50.15%
Revenue Next Year44.2%
Revenue Next 2Y19.59%
Revenue Next 3Y13.15%
Revenue Next 5Y10.36%
EBIT growth 1Y-26.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.07%
EBIT Next 3Y64.18%
EBIT Next 5YN/A
FCF growth 1Y-129.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.91%
OCF growth 3Y25.91%
OCF growth 5Y-32.17%

TEADS HOLDING CO / TEAD Fundamental Analysis FAQ

What is the fundamental rating for TEAD stock?

ChartMill assigns a fundamental rating of 2 / 10 to TEAD.


What is the valuation status for TEAD stock?

ChartMill assigns a valuation rating of 0 / 10 to TEADS HOLDING CO (TEAD). This can be considered as Overvalued.


How profitable is TEADS HOLDING CO (TEAD) stock?

TEADS HOLDING CO (TEAD) has a profitability rating of 2 / 10.


What is the financial health of TEADS HOLDING CO (TEAD) stock?

The financial health rating of TEADS HOLDING CO (TEAD) is 1 / 10.